Fake doctors, misleading claims drive OxyContin China sales Medical Dialogues Bureau21 Nov 2019 12:19 PM ISTSHANGHAI: The Sackler family's opioid empire in the United States is collapsing under an avalanche of litigation over marketing tactics. Their Purdue...
China to launch inspection on production, sale, use of illegal African swine fever vaccines Medical Dialogues Bureau21 Nov 2019 9:00 AM ISTThe ministry has previously warned against the use of such products, after reports of both imported and homemade products being used in China.BEIJING:...
Govt still mulling to bring medical devices under CDSCO: Minister tells parliament Farhat Nasim20 Nov 2019 2:36 PM ISTNew Delhi: The NITI Aayog has not rejected the proposal to bring medical devices under the Central Drugs Standard Control Organisation (CDSCO), the...
Pfizer Abrilada, biosimilar to Humira gets USFDA nod for multiple inflammatory conditions Farhat Nasim20 Nov 2019 12:44 PM ISTNew Delhi: Pfizer Inc. recently announced the United States (U.S.) Food and Drug Administration (USFDA) has approved ABRILADA (adalimumab-afzb), as a...
FIRST: Dr Reddys forays into nutrition segment with launch of diabetes drink Celevida in India Medical Dialogues Bureau20 Nov 2019 12:28 PM ISTM V Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets), Dr Reddy’s Laboratories said, “We are pleased to mark our foray...
Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore Medical Dialogues Bureau20 Nov 2019 9:30 AM ISTSuven Life Sciences provides contract research and manufacturing services to global life sciences companies. It plans to invest 75 million dollars...
Panacea Biotec appoints Rajeeva Kumar Mangalum as Chief Operating Officer for pharmaceutical operations Medical Dialogues Bureau20 Nov 2019 9:15 AM ISTPanacea Biotec announced the elevation of Rajeeva Kumar Mangalum as Chief Operating Officer for the pharmaceutical operations and Dinesh Singla as...
OxyContin maker Purdue Pharma gets court approval for covering plaintiffs fees Medical Dialogues Bureau20 Nov 2019 9:00 AM ISTOxyContin maker Purdue proposed a $200 million emergency fund last month that could be spent quickly on addiction treatment while the parties resolve...
USFDA pulls up Mylan for manufacturing violations at Andhra plant Medical Dialogues Bureau19 Nov 2019 4:40 PM ISTNew Delhi: American health regulator USFDA has pulled up Mylan Laboratories for violation of good manufacturing norms, including lapses in handling...
Novartis shifts Shanghai's focus from research to early development Medical Dialogues Bureau19 Nov 2019 12:53 PM ISTZURICH: Novartis is halting early-stage research in Shanghai and shifting the site's focus to commercial development three years after the Swiss...
NCLAT rejects Dhanuka Labs Rs 1146 crore bid for Orchid Pharma for being less than Liquidation Value Medical Dialogues Bureau19 Nov 2019 12:36 PM ISTNew Delhi: The NCLAT has rejected the bid of Dhanuka Laboratories for the debt ridden Orchid Pharma, and vacated the order passed by the Chennai-bench...
Pharmacists to protest at Jantar Mantar against amendment of Schedule K of Drugs and Cosmetics Act Farhat Nasim18 Nov 2019 2:55 PM ISTNew Delhi: The Indian Pharmacist Association (IPA) has decided to conduct a protest on November 29 at Jantar Mantar against the recent draft to amend...
